Topics

Companies Related to "approved drug repair leakiness types bowel disease" [Most Relevant Company Matches] RSS

16:50 EST 19th February 2020 | BioPortfolio

Here are the most relevant search results for "approved drug repair leakiness types bowel disease" found in our extensive corporate database of over 50,000 company records.

Showing "approved drug repair leakiness types bowel disease" Companies 1–25 of 6,700+

Relevant

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...


Jaguar Health, Inc.

Jaguar Health, Inc. is a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal ...

Aerpio Therapeutics

Aerpio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease. Aerpio is a leader in the development of small molecule drugs based on Tie-2 activation and the stabilization of Hypoxia-inducible Factor 1α (HIF-1α). The company’s ...


Aerpio Therapeutics, Inc.

Aerpio Therapeutics, Inc. is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease. Aerpio is a leader in the development of small molecule drugs based on Tie2 activation and the stabilization of Hypoxia-inducible Factor 1α (HIF‐1α). The Company...

Nova Molecular Incorporated

Nova Molecular Inc. (NMI) is a Montreal based CNS drug discovery company focused on understanding neuronal degeneration, disease progression, repair mechanisms, therapeutic response and development based on our proprietary neuron repair biology platform. NMI’s lead Alzheimer’s compound is also under investigation for a number of other CNS neurodegenerative indications such as Parkinson’s, mu...

Osiris Therapeutics

Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues. The next revolution in medical care Osiris Therapeutics is commercializing products from a readily available and non-controversial source – adult bone marrow. These st...

Cervical Cancer-Free America

Cervical cancer is caused by persistent infections with high-risk types of the human papillomavirus (HPV). HPV is a very common sexually transmitted infection that 3 of 4 adults will have at some time in their lives. HPV vaccines are now available and target the two types of HPV that are responsible for 70 percent of all cervical cancers and are FDA-approved for girls and young women up to age 26....

Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

The Myelin Repair Foundation (MRF)

The Myelin Repair Foundation (MRF) - http://www.myelinrepair.org - is a Northern California-based, non-profit research organization focused on accelerating discovery and development of myelin repair therapeutics for multiple sclerosis. Its Accelerated Research Collaboration™ Model is designed to optimize the entire process of medical research, drug de...

AVI BioPharma

AVI BioPharma is an emerging biopharmaceutical company and a pioneer in the development of therapeutic products based upon three platform technologies: - therapeutic cancer vaccines, - gene-targeted drugs (antisense), and, - drug delivery technologies.The Company focuses its three platform technologies on two important clinical areas, cancer and cardiovascular disease. The Company ...

BiPar Sciences, Inc.

BiPar Sciences is a drug development company with a therapeutic focus on exploring novel mechanisms of action in oncology. The lead development program is based on DNA repair, specifically with poly ADP-ribose polymerase (PARP) inhibitors. The lead product within that program is BSI-201, a platform drug with the potential to be a superior new treatment across a range of tumor types, both as mo...

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervous system disorders. History of Successful Drug Discovery NPS has a history of successful drug discovery. With one approved product on the market and several more in development, NPS's discovery capab...

BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling...

Lexicon Pharmaceuticals, Inc.

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identif...

Alizyme Therapeutics Limited

Alizyme is a drug development company. It develops new products to treat diseases with high unmet medical need and substantial market opportunity. To date it has focussed on obesity and related diseases, such as diabetes, and on gastrointestinal disorders including irritable bowel syndrome, inflammatory bowel disease and mucositis, a serious side effect of cancer therapy.Alizyme takes drug product...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

Trucode Gene Repair

Trucode Gene Repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. The elegance of triplex gene editing lies in its ability to harness natural, high-fidelity DNA repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors. Trucode is hea...

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. www.consynance.com

Amakem

Amakem NV is a biopharmaceutical company developing safe and effective kinase inhibitors using its "Localized Drug Action" platform for the treatment of diseases, such as COPD, glaucoma and inflammatory bowel disease. The company focuses on the development of promising and innovative near clinical or clinical small molecule drugs.

Transave Inc.

Transave is a biotechnology company focused on the site specific treatment of lung disease. The company’s goal is to achieve the leadership role in the treatment of lung diseases via the use of its proprietary Sustained release Lipid Inhalation Targeting (SLIT™) technology. The Company’s low risk business model is focused predominantly on developing inhaleable sustained release formulations ...

SFA Therapeutics, Inc.

SFA Therapeutics, Inc. is a bio-pharmaceutical company focused on new human microbiome-based advancements in the treatment of inflammatory diseases, targeting NF-KB mediated pathways. Chronic inflammation has been implicated in a wide range of diseases, including Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Lupus (SLE), Inflammatory Bowel Disease ...

Thrasos Therapeutics

Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Thrasos’...

Creative BioMolecules Incorporated

Creative BioMolecules, Inc. is a biopharmaceutical company focused on the development of products for human tissue regeneration and repair. Creative BioMolecules' core technologies are based on our understanding of the role that morphogenic proteins play in human biology. These proteins are involved in the initiation and regulation of the cellular events responsible for the formation of human tiss...

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. ConSynance are collaborating with Chengdu SciMount Pharmatech Co., Ltd., a drug discov...

Colgate Total

Colgate Total® toothpaste has an antibacterial formula clinically proven to actively fight germs for 12 hours. It is the only toothpaste both approved* by the U.S. Food and Drug Administration (FDA) and accepted by the American Dental Association to fight plaque and gingivitis. Colgate Total® toothpaste is also the number one toothpaste recommended most by dentists and hygienists. It has not be...


More From BioPortfolio on "approved drug repair leakiness types bowel disease"

Quick Search

Corporate Database Quicklinks